Liver lipopolysaccharide binding protein prevents hepatic inflammation in physiological and pathological non-obesogenic conditions-Reference-Cited by-同舟云学术

Liver lipopolysaccharide binding protein prevents hepatic inflammation in physiological and pathological non-obesogenic conditions

Published:2023-01 Issue: Volume:187 Page:106562
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Milbank Edward,Díaz-Trelles Ramon,Dragano Nathalia,Latorre Jèssica,Mukthavaram Rajesh,Mayneris-Perxachs Jordi,Ortega Francisco,Federici Massimo,Burcelin Remy,Karmali Priya P.,Tachikawa Kiyoshi,Chivukula Pad,López Miguel,Fernández-Real José Manuel,Moreno-Navarrete José María

Funder

Federación Española de Enfermedades Raras

Instituto de Salud Carlos III

Fundació la Marató de TV3

Publisher

Elsevier BV

Subject

Pharmacology

Reference32 articles.

1. High concentrations of lipopolysaccharide-binding protein in serum of patients with severe sepsis or septic shock inhibit the lipopolysaccharide response in human monocytes;Zweigner;Blood,2001

2. Bovine recombinant lipopolysaccharide binding protein (BRLBP) regulated apoptosis and inflammation response in lipopolysaccharide-challenged bovine mammary epithelial cells (BMEC);Sun;Mol. Immunol.,2015

3. Dual role of lipopolysaccharide (LPS)-binding protein in neutralization of LPS and enhancement of LPS-induced activation of mononuclear cells;Gutsmann;Infect. Immun.,2001